Back to top

Analyst Blog

We have reiterated our Neutral recommendation on Perrigo Company (PRGO - Analyst Report) with a target price of $113.00. The stock carries a Zacks #3 Rank (Hold) in the short run.

Maintaining Neutral Stance

Perrigo delivered mixed numbers in the first quarter of fiscal 2013 (ended September 29, 2012). Though revenues were short of the Zacks Consensus Estimate, earnings were ahead of the Zacks Consensus Estimate. The company expects fiscal 2013 earnings to grow in the range of 9-13% over fiscal 2012 levels.

We are impressed by Perrigo’s growth-by-acquisition strategy. The company is constantly making acquisitions to expand its business and drive growth. In December 2012, Perrigo acquired privately-held Cobrek Pharmaceuticals, Inc. for approximately $45 million in cash. In January 2012, Perrigo inked a deal to acquire the assets of Georgia-based private company CanAm Care, thereby expanding its presence in the diabetes care market.

In July 2011, Perrigo acquired Paddock Labs to expand its generic Rx business. In April 2010, Perrigo acquired PBM Holdings, Inc., a leading manufacturer and distributor of store brand infant formulas, pediatric nutritional and baby food. Other important acquisitions include Galpharm, Diba and Orion Laboratories. Such prudent acquisitions should drive growth at Perrigo in the coming quarters.

We are also impressed by the series of launches at the generic (Rx Pharmaceuticals) segment of Perrigo. Though encouraged by Perrigo’s strong position in the brand over the counter pharmaceutical market and growing generics and Active Pharmaceutical Ingredientsbusinesses, we remain concerned about the uninspiring performance by the Consumer HealthCaresegment, which accounts for the majority of the company’s revenues.

Other Stocks to Consider

We prefer to remain on the sidelines on Perrigo, an S&P 500 stock. S&P companies that currently look better-positioned include Mylan Inc. (MYL - Analyst Report), which carries a Zacks #2 Rank (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.80 +7.04%
TRAVELCENTE… TA 11.84 +6.38%
BANCO DO BR… BDORY 14.74 +5.66%
AIR INDUSTR… AIRI 9.99 +4.15%
EQT MIDSTRE… EQM 98.14 +3.38%